We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Laboratory Test Identifies Patients Infected With Swine Flu Virus

By LabMedica International staff writers
Posted on 27 May 2009
A laboratory test has been developed for identification of the virus that causes swine flu. More...


Swine flu is a respiratory disease that is caused by the H1N1 serotype of influenza A virus. The influenza A virus infects mainly humans, pigs, and birds. Scientists believe that the H1N1 subtype has mutated from a type that primarily infected pigs into a new form that is now transmissible through direct human-to-human contact.

Quest Diagnostics (Madison, NJ, USA), through its Focus Diagnostics (Cypress, CA, USA) infectious disease reference laboratory, has introduced a laboratory-developed RNA real-time polymerase chain reaction (PCR) test to aid in identifying novel swine flu virus infection.

Physicians can order the new Focus Diagnostics test to aid in the diagnosis of influenza A virus including the H1N1 serotype. It will be possible to submit patient specimens that are found to be positive for influenza A virus by a Quest Diagnostics' regional laboratory (or other clinical laboratory) to the Focus Diagnostics reference laboratory to determine whether the virus is the H1N1 serotype responsible for swine flu.

Quest Diagnostics provides different laboratory techniques including polymerase chain reaction (PCR), rapid cell culture, direct immunofluorescence (DFA), and enzyme immunoassay (EIA) testing. The Influenzavirus A testing services use specimens that include nasopharyngeal swabs, nasal secretions, nasal wash (lavage), and aspirations.

For more information on Swine flu and what you can do to minimize infection, see the U.S. Centers for Disease Control and Prevention's (CDC; Atlanta, GA, USA) web information on Swine Flu below.

Related Links:

Quest Diagnostics
Focus Diagnostics
U.S. Centers for Disease Control and Prevention
Web information on Swine Flu



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.